Substitution of Moxifloxacin for Isoniazid During Intensive Phase Treatment of Pulmonary Tuberculosis

American Journal of Respiratory and Critical Care Medicine - United States
doi 10.1164/rccm.200901-0078oc
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis

InPharma
1988English

Rational Use of Moxifloxacin for Tuberculosis Treatment

The Lancet Infectious Diseases
Infectious Diseases
2011English

High-Dose Vitamin D3 During Intensive-Phase Antimicrobial Treatment of Pulmonary Tuberculosis: A Double-Blind Randomised Controlled Trial

The Lancet
Medicine
2011English

Myelopathy During Treatment for Pulmonary Tuberculosis.

Postgraduate Medical Journal
Medicine
1980English

T-SPOT.TBresponses During Treatment of Pulmonary Tuberculosis

BMC Infectious Diseases
Infectious Diseases
2009English

Isoniazid in Treatment of Bone and Joint Tuberculosis

BMJ
1954English

Cytokines and Acute-Phase Serum Proteins as Markers of Inflammatory Regression During Pulmonary Tuberculosis Treatment

Journal of Venomous Animals and Toxins Including Tropical Diseases
Animal ScienceZoologyParasitologyInfectious DiseasesToxicology
2008English

Effect of Isoniazid Resistance on the Tuberculosis Treatment Outcome

Archivos de Bronconeumologia
PulmonaryRespiratory Medicine
2018English

Isoniazid Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy